{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-7/paragraph-13C",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/schedule-7/paragraph-13C.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "schedule/7/paragraph/13C",
  "kind": "paragraph",
  "number": "13C",
  "heading": "Contact via NHS.net Connect and the Central Alerting System",
  "text": "(1) An LPS chemist (C) must ensure that pharmacy staff at listed premises (including locums) have access to, and are able to send and receive messages via NHS.net Connect from, a premises specific NHS.net Connect account.\n(2) C must ensure that at least two members of the pharmacy staff have live, linked NHS.net Connect accounts to the premises specific NHS.net Connect account (unless fewer than two members of the pharmacy staff are engaged in the provision of NHS services).\n(3) As regards the Central Alerting System (CAS) operated by the Medicines and Healthcare products Regulatory Agency (MHRA)—\n(a) C must register C’s premises specific NHS.net Connect address with MHRA as an address at which C is content to accept notifications as part of the CAS (unless they are content with the address already in the system);\n(b) if C changes C’s premises specific NHS.net Connect address, P must immediately notify MHRA of C’s new premises specific NHS.net Connect address, in accordance with paragraph (a); and\n(c) C must monitor C’s premises specific NHS.net Connect account with sufficient frequency to ensure the safe and effective supply of medicinal products at or from C’s pharmacy premises, and must act on the alerts C receives as part of the CAS, as appropriate.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 7 paras. 13B, 13C inserted (9.11.2020) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2020 (S.I. 2020/1126), regs. 1(2), 28"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in Sch. 7 para. 13C(1) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(b)(i)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Words in Sch. 7 para. 13C(1) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(b)(ii)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in Sch. 7 para. 13C(2) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(c)"
    },
    {
      "type": "F",
      "label": "F5",
      "text": "Words in Sch. 7 para. 13C(3)(a) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(d)(i)"
    },
    {
      "type": "F",
      "label": "F6",
      "text": "Words in Sch. 7 para. 13C(3)(b) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(d)(ii)"
    },
    {
      "type": "F",
      "label": "F7",
      "text": "Words in Sch. 7 para. 13C(3)(c) substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(d)(iii)"
    },
    {
      "type": "F",
      "label": "F8",
      "text": "Words in Sch. 7 para. 13C heading substituted (1.10.2025) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Miscellaneous Amendments) Regulations 2025 (S.I. 2025/989), regs. 1(2), 66(2)(a)"
    }
  ],
  "outstanding_effects": [
    {
      "type": "inserted",
      "affecting": "uksi/2026/961",
      "affecting_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/schedule/7/paragraph/13C",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}